sports medicine News
-
Early detection of concussion can mitigate premature returning to play decisions
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). More on Zack Lystadt's concussion survivor's journey (here). ...
-
Alejandro Lucia, researcher at the European University and collaborator of Microviable Therapeutics, National Award for Research in Sports Medicine.
It is always a pleasure to work with prestigious researchers. Congratulations Alejandro Lucia! for the award received. A group of ten researchers from various institutions, including Alejandro Lucia, a researcher at the European University and a Microviable collaborator, have received the Cajastur Foundation National Research Award in Sports Medicine, convened by the University of Oviedo, for ...
-
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesday, March 22nd at 11:00 a.m. Central Time. A webcast of the presentation will be available on the Investor Relations section of the ...
-
Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Wednesday, March 9th at 1:30 p.m. Eastern Time. A webcast of the presentation will be available on the Investor Relations section of ...
-
Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021, at 4:15p.m. Eastern Time. A webcast of the presentation will be available on the ...
-
Biorez Wins Major Award at Top Sports Medicine Conference for Its BioBrace Implant
Biorez Inc., a New Haven start-up advancing tendon and ligament healing, announced today that its proprietary, and recently FDA-cleared BioBrace Implant, received the AOSSM ACE Award for ‘Accelerating the Cutting Edge.’ The award was given at the annual meeting of the American Orthopaedic Society for Sports Medicine (AOSSM), held jointly with the Arthroscopy Association of ...
By Biorez Inc.
-
Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Ladenburg Thalmann Healthcare Conference. The conference is being conducted in a virtual format and the presentation will take place on Tuesday, July 13, 2021, at 9:00 a.m. ...
-
Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. Eastern Time. A webcast of the presentation will be available on the Investor Relations section of the Vericel ...
-
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on Thursday November 18th, at 10:00a.m. Eastern Time. A webcast of the presentation will be available on the Investor ...
-
Biorez Adds Two Esteemed Surgeons to its Scientific Advisory Board
Biorez Inc., a start-up advancing tendon and ligament healing with its proprietary BioBrace Technology, announced today that the company is expanding its scientific advisory board to include Drs. Joseph Burns of Atlanta and Deryk G. Jones of New Orleans. “Drs. Burns and Jones are both accomplished surgeons, thought leaders, and published researchers in sports medicine, and we are ...
By Biorez Inc.
-
Gulf Breeze, FL sports medicine practice named Sonex Health Center of Excellence
Dr. Brett Kindle’s sports medicine practice in Gulf Breeze, Florida, has been selected by Sonex Health, Inc. as a Center of Excellence for carpal tunnel release (CTR) using the SX-One MicroKnife® and real-time ultrasound guidance. Since October 2018, Dr. Kindle has performed more than 250 procedures, noting that patients are typically able to return to normal activity in 3-6 days. ...
-
BioPoly Granted Another US Patent
FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly® material, which is currently being used to replace damaged cartilage in joints. Where some of the other BioPoly patents address the design of the implants, this patent family focuses on the material itself. This most recent patent, regarding material derivatives, adds to the ...
By BioPoly, LLC
-
SANUWAVE Business Update
SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, has announced they will be updating shareholders on a monthly basis during 2022 with regards to their Sales Funnel and System Trials. This news comes simultaneously with the company’s announcement for growth through a medical non-wound care vertical market expansion. Both the Sales Funnel, defined as ...
-
Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it has entered into a long-term lease agreement for a new state-of-the-art advanced cell therapy manufacturing and corporate headquarters facility at the Network Drive campus at Northwest Park in Burlington, Massachusetts. The new facility, which will ...
-
Medical Device Company Lazurite Announces Agreement with UH Ventures to Conduct Formative Human Factors Study on its ArthroFree™ Wireless Surgical Camera
Medical device and technology company Lazurite Holdings LLC (formerly Indago) today announced that it has contracted with University Hospitals (UH) Ventures – the innovation and commercialization arm of University Hospitals Health System in Cleveland – to conduct a formative human factors study on its ArthroFree™ wireless surgical camera as part of a broader multisite study. ...
-
Appointment of Patryk Kania as CEO of Field Orthopaedics
Field Orthopaedics is pleased to announce that Patryk Kania has been appointed as the Company’s new Chief Executive Officer (CEO), succeeding Dr Christopher Jeffrey, who stepped aside as CEO and Board member by mutual agreement earlier this year. Patryk has been acting as CEO while the Board worked through Dr Jeffery’s contractual release, which has only just been ...
-
Panag Pharma Announces Launch Of A Regional Pilot Program
Halifax, Nova Scotia. Panag Pharma hosted a seminar for Health Care Professionals and the launch of a Regional Pilot Program to introduce Topical AOTC, a new generation pain and inflammation product. Topical AOTC is a Health Canada approved natural product indicated for temporarily relief of aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains and ...
-
Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of Patrick J. Fowler as Senior Vice President, Corporate Development and Strategy, effective today. Mr. Fowler joins Vericel with over 15 years of business development, strategy and commercial operations experience in the biotech and medical technology ...
-
100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant
Active Implants, LLC, a company that develops orthopedic implant solutions, today announced enrollment of the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorating meniscus tissue. The surgery was performed by orthopedic surgeon Dr. Wayne Gersoff of Advanced Orthopedics & Sports Medicine ...
-
CONMED Announces Definitive Agreement to Acquire Biorez, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be ...
By Biorez Inc.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you